WO2024047506 - A NOVEL CRYSTALLINE FORM OF PRITELIVIR
National phase entry:
Publication Number
WO/2024/047506
Publication Date
07.03.2024
International Application No.
PCT/IB2023/058486
International Filing Date
28.08.2023
Title **
[English]
A NOVEL CRYSTALLINE FORM OF PRITELIVIR
[French]
NOUVELLE FORME CRISTALLINE DE PRITELIVIR
Applicants **
ASSEMBLY BIOSCIENCES, INC.
Inventors
ZONG, Zhixin
WHITE, Nicole
WU, Yi
Priority Data
63/373,741
29.08.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2101 | |
| EPO | Filing, Examination, Granting | 8856 | |
| Japan | Filing, Examination, Granting | 2230 | |
| South Korea | Filing, Examination, Granting | 2066 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
21,193
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to a novel crystalline form of pritelivir, as well as to pharmaceutical compositions comprising the same, and to methods for its production and use of the crystalline form in a medicament and for the treatment of herpes virus.[French]
L'invention concerne une nouvelle forme cristalline de pritelivir, ainsi que des compositions pharmaceutiques comprenant celle-ci, et des procédés pour sa production et l'utilisation de la forme cristalline dans un médicament et pour le traitement du virus de l'herpès.